In vitro study on the interaction between thiophanate methyl and human serum albumin

Jinhua Li1, Xiaoyan Liu, Cuiling Ren

  • 1Department of Chemistry, Lanzhou University, No. 222 Tianshui Road, Lanzhou 730000, China.

Insights

Thiophanate methyl (MT), a common fungicide, binds to human serum albumin (HSA). This interaction, driven by hydrophobic forces and hydrogen bonds, alters HSA

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacology

Background:

  • Thiophanate methyl (MT) is a widely used fungicide, posing potential toxicological risks.
  • Human serum albumin (HSA) is a primary transporter of xenobiotics in blood plasma.
  • Understanding xenobiotic-protein interactions is crucial for assessing toxicological impact.

Purpose of the Study:

  • To investigate the binding interaction between thiophanate methyl (MT) and human serum albumin (HSA).
  • To elucidate the binding mechanism and thermodynamic properties of the MT-HSA complex.
  • To determine the conformational changes in HSA upon binding with MT.

Main Methods:

  • Spectroscopic techniques: Fluorescence quenching, UV-Vis absorption, and Fourier transform infrared (FT-IR) spectroscopy.
  • Simulated physiological conditions for binding studies.
  • Molecular modeling for predicting binding modes and forces.

Main Results:

  • MT effectively quenched the intrinsic fluorescence of HSA, indicating binding.
  • Thermodynamic analysis revealed a spontaneous and exothermic binding process.
  • FT-IR spectroscopy demonstrated that MT binding induced conformational changes in HSA.
  • Molecular modeling identified hydrophobic interactions and hydrogen bonds as dominant forces in MT-HSA binding.

Conclusions:

  • Thiophanate methyl binds to human serum albumin through spontaneous, exothermic interactions.
  • The binding involves hydrophobic forces and hydrogen bonds, leading to HSA conformational alterations.
  • These findings provide insights into the toxicokinetics and toxicodynamics of thiophanate methyl.

Related Concept Videos